Eren Demirhan, PhD, MBA, is a seasoned professional in drug development strategy, biostatistics, and advanced analytics, currently serving as the Vice President and Global Head of Early Development Biometrics at Roche since 2025. Previously, Eren held key positions, including Director of Biostatistics at Allogene Therapeutics and Pfizer, and Sr. Biostatistician at Biogen. Eren's educational background includes a PhD in Statistics from North Carolina State University and an MBA from the University of North Carolina at Chapel Hill. Eren has also contributed to the field through innovative roles at Nurix Therapeutics and ZS.
Location
San Francisco, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices